Vanda Pharmaceuticals Inc VNDA

NAS: VNDA | ISIN: US9216591084 14/09/2026

5,150 USD (+1,18%)

(+1,18%) 14/09/2026

Grafiek Vanda Pharmaceuticals Inc

Grafiek Vanda Pharmaceuticals Inc

1 dag1d 1,18%
1 week1w -3,38%
1 maand1m -2,09%
3 maanden3m -12,41%
6 maanden6m -41,54%
1 jaar1j 17,58%
5 jaar5j -68,48%

Vanda Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

2 september 2026 · Vanda Pharmaceuticals Announces Participation at September 2026 Investor Conferences · Persbericht

24 augustus 2026 · Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission · Persbericht

22 augustus 2026 · NEREUS™ Sponsored No. 47 IndyCar Ready for Historic Freedom 250 Grand Prix in Washington, D.C. · Persbericht

5 augustus 2026 · Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results · Persbericht

29 juli 2026 · Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 · Persbericht

16 juli 2026 · Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe · Persbericht

15 juli 2026 · NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment · Persbericht

10 juli 2026 · Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit · Persbericht

7 juli 2026 · Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S · Persbericht

27 mei 2026 · Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis · Persbericht

Profiel Vanda Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.vandapharma.com

Hoofdzetel: Washington, Washington Dc Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe